Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis-Reference-Cited by-同舟云学术

Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis

Published:2015-07 Issue:4 Volume:95 Page:463-469
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Mzinza David T.^ORCID,Sloan Derek J.,Jambo Kondwani C.,Shani Doris,Kamdolozi Mercy,Wilkinson Katalin A.^ORCID,Wilkinson Robert J.^ORCID,Davies Geraint R.,Heyderman Robert S.^ORCID,Mwandumba Henry C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference37 articles.

1. IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection;Green;J Immunol,2013

2. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection;Flynn;J Exp Med,1993

3. Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse;Pearl;Cell Immunol,2001

4. Mycobacterium tuberculosis control by lung macrophages and CD 8 cells from patient contacts;Carranza;Am J Respir Crit Care Med,2006

5. A comparison of IFN-gamma detection methods used in tuberculosis vaccine trials;Beveridge;Tuberculosis,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi;Wellcome Open Research;2023-06-12

2. Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi;Wellcome Open Research;2023-02-10

3. T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis;Vaccine: X;2022-08